You are here: Home » Companies » News
Business Standard

Drug pricing regulator NPPA okays hike in prices of cardiac stents by 4.2%

A coronary stent is a tube-shaped device placed in the arteries that supplies blood to the heart

Press Trust of India  |  New Delhi 

coronary stent
Representative image of a coronary stent

Drug price regulator has approved a hike in prices of by 4.2 per cent in-line with the wholesale price index (WPI) of the previous calendar year, according to an official statement.

As per the new prices notified by the (NPPA), a (BMS) would now cost Rs 8,261, while the drug-eluting stent (DES) will cost Rs 30,080.

"After considering the WPI at 4.26 per cent for the year 2018 over 2017, it has been decided to revise the with effect from April 1, 2019," the said in a statement.

The drug pricing authority had earlier revised the in February last year. It had increased the prices of bare metal stents from Rs 7,400 to Rs 7,660. On the other hand, it had reduced the price of DES to Rs 27,890 from Rs 30,180.

Providing a major relief to lakhs of cardiac patients, the government had for the first time cut prices of life-saving by up to 85 per cent in February 2017.

BMS used to cost as much as Rs 45,000 and DES Rs 1,21 lakh prior to the imposition of the price cap in February 2017.

A coronary stent is a tube-shaped device placed in the arteries that supplies blood to the heart. It keeps the arteries open in the treatment of

The also said in a separate statement that it has revised ceiling/ retail prices of 871 formulations under Drugs (Price Control) Order, 2013.

First Published: Mon, April 01 2019. 15:30 IST
RECOMMENDED FOR YOU